Literature DB >> 6745720

Comparison of faecal bile acid profiles between patients with adenomatous polyps of the large bowel and healthy subjects in Japan.

N Tanida, Y Hikasa, T Shimoyama, K D Setchell.   

Abstract

Faecal bile acid excretion was examined in 13 patients with adenomatous polyps of the large bowel and compared with a series of matched healthy subjects. Bile acids were analysed in detail with respect to the composition of individual bile acids and their mode of conjugation. The total excretion of bile acids by the patient group and the healthy subjects ranged from 55.0-837.6 mumol/day (median 233.8, mean 346.9) and 93.8-712.3 mumol/day (median 489.2, mean 386.7) respectively. Expressed as mumol/g faecal weight these values were 0.6-4.8 (median 2.2, mean 2.4) and 0.4-5.8 (median 2.2, mean 2.8) and in terms of mumol/g faecal dry weight, 1.9-50.7 (median 10.1, mean 16.5) and 3.9-32.4 (median 16.3, mean 16.7) respectively for the two groups. The composition of the individual bile acids and their distribution within the various conjugate fractions was essentially the same for both groups. Cholenoic acid (5 beta-chol-3-enoic acid), an unusual bile acid, was detected in one patient and three healthy subjects. These results revealed no significant quantitative differences in bile acid excretion between the group of patients with adenomatous polyps and those of healthy subjects.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6745720      PMCID: PMC1432564          DOI: 10.1136/gut.25.8.824

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  39 in total

1.  QUANTITATIVE ISOLATION AND GAS--LIQUID CHROMATOGRAPHIC ANALYSIS OF TOTAL FECAL BILE ACIDS.

Authors:  S M GRUNDY; E H AHRENS; T A MIETTINEN
Journal:  J Lipid Res       Date:  1965-07       Impact factor: 5.922

Review 2.  Premalignancy of polyps of the colon.

Authors:  W L Buntain; W H ReMine; G M Farrow
Journal:  Surg Gynecol Obstet       Date:  1972-03

3.  Degradation of steroids by intestinal bacteria. IV. The aromatisation of ring A.

Authors:  P Goddard; M J Hill
Journal:  Biochim Biophys Acta       Date:  1972-10-05

4.  Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N'-nitro-N-nitrosoguanidine in rats.

Authors:  T Narisawa; N E Magadia; J H Weisburger; E L Wynder
Journal:  J Natl Cancer Inst       Date:  1974-10       Impact factor: 13.506

5.  President's address. The polyp-cancer sequence in the large bowel.

Authors:  B Morson
Journal:  Proc R Soc Med       Date:  1974-06

6.  Polyps of the colon and rectum in Cali, Colombia.

Authors:  P Correa; E Duque; C Cuello; W Haenszel
Journal:  Int J Cancer       Date:  1972-01-15       Impact factor: 7.396

7.  The effect of some factors on the faecal concentration of acid steroids, neutral steroids and urobilins.

Authors:  M J Hill
Journal:  J Pathol       Date:  1971-08       Impact factor: 7.996

8.  Bacteria and the aetiology of cancer of the large bowel.

Authors:  V Aries; J S Crowther; B S Drasar; M J Hill; R E Williams
Journal:  Gut       Date:  1969-05       Impact factor: 23.059

9.  Bacteria and aetiology of cancer of large bowel.

Authors:  M J Hill; B S Drasar; G Hawksworth; V Aries; J S Crowther; R E Williams
Journal:  Lancet       Date:  1971-01-16       Impact factor: 79.321

10.  Faecal bile-acids and clostridia in patients with cancer of the large bowel.

Authors:  M J Hill; B S Drasar; R E Williams; T W Meade; A G Cox; J E Simpson; B C Morson
Journal:  Lancet       Date:  1975-03-08       Impact factor: 79.321

View more
  12 in total

1.  Analysis of bile acids in colon residual liquid or fecal material in patients with colorectal neoplasia and control subjects.

Authors:  T Kishida; F Taguchi; L Feng; A Tatsuguchi; J Sato; S Fujimori; H Tachikawa; Y Tamagawa; Y Yoshida; M Kobayashi
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

2.  Experimental colonic carcinogenesis: changes in faecal bile acids after promotion of intestinal tumours by small bowel resection in the rat.

Authors:  A P Savage; M S Sian; J L Matthews; S R Bloom; T Cooke
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

3.  Influence of age, intestinal transit time, and dietary composition on fecal bile acid profiles in healthy subjects.

Authors:  F M Nagengast; S D van der Werf; H L Lamers; M P Hectors; W C Buys; J M van Tongeren
Journal:  Dig Dis Sci       Date:  1988-06       Impact factor: 3.199

4.  High concentration and retained amidation of fecal bile acids in patients with active ulcerative colitis.

Authors:  N Tanida; Y Hikasa; M Dodo; K Sawada; A Kawaura; T Shimoyama
Journal:  Gastroenterol Jpn       Date:  1986-06

5.  Faecal unconjugated bile acids in patients with colorectal cancer or polyps.

Authors:  C H Imray; S Radley; A Davis; G Barker; C W Hendrickse; I A Donovan; A M Lawson; P R Baker; J P Neoptolemos
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

6.  Relationship between duodenal bile acids and colorectal neoplasia.

Authors:  R J Moorehead; G R Campbell; J D Donaldson; S T McKelvey
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

7.  Faecal bile acid profiles in patients with large bowel cancer in Japan.

Authors:  Y Hikasa; N Tanida; T Ohno; T Shimoyama
Journal:  Gut       Date:  1984-08       Impact factor: 23.059

8.  Formation of delta 2- and delta 3-cholenoic acids from bile acid 3-sulfates by a human intestinal Fusobacterium strain.

Authors:  J Robben; G Janssen; R Merckx; H Eyssen
Journal:  Appl Environ Microbiol       Date:  1989-11       Impact factor: 4.792

9.  Unconjugated secondary bile acids in the serum of patients with colorectal adenomas.

Authors:  E Bayerdörffer; G A Mannes; T Ochsenkühn; P Dirschedl; B Wiebecke; G Paumgartner
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

10.  Association between fecal bile acids and colorectal cancer: a meta-analysis of observational studies.

Authors:  Jin Lu Tong; Zhi Hua Ran; Jun Shen; Guo Quan Fan; Shu Dong Xiao
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.